BioInformant has released a 21-page, 50+ respondent survey in which cell therapy manufacturing executives reveal when and why they choose to partner with a cell therapy contact manufacturing organization (CMO).

Importantly, it reveals the selection criteria that cell therapy executives use to select a CMO partner, as well as their perspectives on: 

For a geographic breakdown of the respondents, 40% were from the USA, 20% were from Europe, 16% were from Asia, 5% were from South America, and 19% were rest-of-world (ROW).

This cell therapy manufacturing survey of 50+ respondents is an indispensable resource for CMOs specializing in the rapidly evolving cell therapy therapy industry, because it reveals how cell therapy executives think about CMO selection.

For cell therapy companies, it reveals the criteria that your competitors are using to select CMO partners. 

For the next 48 hours, you can claim this 21-page survey for only $97 (50% off) and have access to it for life.